Navigation Links
Omeros to Present at Deutsche Bank Securities Health Care Conference
Date:5/2/2012

SEATTLE, May 2, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Deutsche Bank Securities 37th Annual Health Care Conference next week. The presentation is scheduled for 10:00 a.m. Eastern Time on Wednesday, May 9, 2012.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros Names Dr. Patrick Gray as Scientific Fellow
2. Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
3. BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle
4. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
5. Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference
6. Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302
7. Omeros Unlocks Four Additional Orphan GPCRs
8. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
9. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
10. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
11. Omeros Corporation Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... , May 5, 2017  Hill-Rom Holdings, Inc. ... add approximately 100,000 square feet to its Welch Allyn ... 2016 its commitment to bring more than 100 new ... where Welch Allyn has maintained a significant presence for ... accommodate these new positions, a large portion of which ...
(Date:5/4/2017)... LAWRENCE, Mass. and SAN DIEGO ... of Obstetricians and Gynecologists (ACOG) 2017 Annual Clinical and ... of single-use, self-contained, illuminating medical devices, today announced the ... size of its OfficeSPEC and ER-SPEC ... large, the addition of extra-small and extra-large sizes makes ...
(Date:5/3/2017)... , May 3, 2017 A ... any hospital or healthcare facility. Commonly referred to ... is equipped with diagnostic imaging technology to give ... the heart. In these spaces, a team of ... balloon angioplasty, percutaneous coronary intervention, congenital heart defect ...
Breaking Medicine Technology:
(Date:5/19/2017)... Atlanta, GA (PRWEB) , ... May 19, 2017 , ... ... D. Miller knows the importance of prostate cancer screenings. Early detection of the ... Miller, head of robotic surgery at Georgia Urology , stands alongside the Georgia ...
(Date:5/19/2017)... ... May 18, 2017 , ... CloSYS products which are marketed ... while extremely helpful for mouth and gum health, which is linked to one’s overall ... customers learned quickly of the powerful ways in which CloSYS products immediately helped eliminate ...
(Date:5/19/2017)... ... May 18, 2017 , ... Somnoware, a leading provider of ... physicians to independently dispense CPAP devices and supplies, such as machines, filters, tubing, and ... dispense the devices. Device registration for daily usage data is automated, and a DME ...
(Date:5/18/2017)... ... May 18, 2017 , ... Originally launched to market as the ... Tab. Due to the rapid expansion of their product line, the company believed it ... Now, the HighQ brand will be any tablet product sold by EPIK Learning. ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... VA based educational and charitable organization which sponsors numerous programs and activities aimed ... MURPH Challenge event over Memorial Day Weekend. , The MURPH Challenge, named ...
Breaking Medicine News(10 mins):